CA1316924C - Etheric derivative of 4/3h/-quinazolinone and a process for the preparation thereof - Google Patents
Etheric derivative of 4/3h/-quinazolinone and a process for the preparation thereofInfo
- Publication number
- CA1316924C CA1316924C CA000609601A CA609601A CA1316924C CA 1316924 C CA1316924 C CA 1316924C CA 000609601 A CA000609601 A CA 000609601A CA 609601 A CA609601 A CA 609601A CA 1316924 C CA1316924 C CA 1316924C
- Authority
- CA
- Canada
- Prior art keywords
- quinazolinone
- difluoro
- compound
- acid addition
- ethyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000000034 method Methods 0.000 title claims description 8
- 238000002360 preparation method Methods 0.000 title claims description 6
- 150000001875 compounds Chemical class 0.000 claims abstract description 18
- QMNUDYFKZYBWQX-UHFFFAOYSA-N 1H-quinazolin-4-one Chemical class C1=CC=C2C(=O)N=CNC2=C1 QMNUDYFKZYBWQX-UHFFFAOYSA-N 0.000 claims abstract description 12
- 239000002253 acid Substances 0.000 claims abstract description 12
- 150000003839 salts Chemical class 0.000 claims abstract description 11
- 230000000202 analgesic effect Effects 0.000 claims abstract description 7
- 239000000203 mixture Substances 0.000 claims description 6
- 238000006243 chemical reaction Methods 0.000 claims description 5
- PJXPCBDPDBKEDG-UHFFFAOYSA-N 1-[4-(2-chloroethoxy)phenyl]-2,4-difluorobenzene Chemical group FC1=CC(F)=CC=C1C1=CC=C(OCCCl)C=C1 PJXPCBDPDBKEDG-UHFFFAOYSA-N 0.000 claims description 4
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 3
- DUBSBPFRYLPHDW-UHFFFAOYSA-N 3-[2-[4-(2,4-difluorophenyl)phenoxy]ethyl]quinazolin-4-one Chemical compound FC1=CC(F)=CC=C1C(C=C1)=CC=C1OCCN1C(=O)C2=CC=CC=C2N=C1 DUBSBPFRYLPHDW-UHFFFAOYSA-N 0.000 claims 2
- 239000003937 drug carrier Substances 0.000 claims 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 abstract description 10
- RLFWWDJHLFCNIJ-UHFFFAOYSA-N Aminoantipyrine Natural products CN1C(C)=C(N)C(=O)N1C1=CC=CC=C1 RLFWWDJHLFCNIJ-UHFFFAOYSA-N 0.000 abstract description 5
- RMMXTBMQSGEXHJ-UHFFFAOYSA-N Aminophenazone Chemical compound O=C1C(N(C)C)=C(C)N(C)N1C1=CC=CC=C1 RMMXTBMQSGEXHJ-UHFFFAOYSA-N 0.000 abstract description 5
- 229960000212 aminophenazone Drugs 0.000 abstract description 5
- BILSLNDJAVVEHR-UHFFFAOYSA-N 1-(2-chloroethoxy)-4-phenylbenzene Chemical group C1=CC(OCCCl)=CC=C1C1=CC=CC=C1 BILSLNDJAVVEHR-UHFFFAOYSA-N 0.000 abstract 1
- XZZKSZKORULQSR-UHFFFAOYSA-N 3-[2-(4-phenylphenoxy)ethyl]quinazolin-4-one Chemical class C1=NC2=CC=CC=C2C(=O)N1CCOC(C=C1)=CC=C1C1=CC=CC=C1 XZZKSZKORULQSR-UHFFFAOYSA-N 0.000 abstract 1
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 abstract 1
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 abstract 1
- 230000007059 acute toxicity Effects 0.000 abstract 1
- 231100000403 acute toxicity Toxicity 0.000 abstract 1
- 229960001680 ibuprofen Drugs 0.000 abstract 1
- 229960005489 paracetamol Drugs 0.000 abstract 1
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- ZXNMIUJDTOMBPV-UHFFFAOYSA-N 2-chloroethyl 4-methylbenzenesulfonate Chemical compound CC1=CC=C(S(=O)(=O)OCCCl)C=C1 ZXNMIUJDTOMBPV-UHFFFAOYSA-N 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- HTSGKJQDMSTCGS-UHFFFAOYSA-N 1,4-bis(4-chlorophenyl)-2-(4-methylphenyl)sulfonylbutane-1,4-dione Chemical compound C1=CC(C)=CC=C1S(=O)(=O)C(C(=O)C=1C=CC(Cl)=CC=1)CC(=O)C1=CC=C(Cl)C=C1 HTSGKJQDMSTCGS-UHFFFAOYSA-N 0.000 description 2
- ASOVDRYKVVVCIA-UHFFFAOYSA-N 4-(2,4-difluorophenyl)phenol Chemical group C1=CC(O)=CC=C1C1=CC=C(F)C=C1F ASOVDRYKVVVCIA-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 2
- 239000000730 antalgic agent Substances 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- ZUOUZKKEUPVFJK-UHFFFAOYSA-N diphenyl Chemical compound C1=CC=CC=C1C1=CC=CC=C1 ZUOUZKKEUPVFJK-UHFFFAOYSA-N 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 150000007522 mineralic acids Chemical class 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- CPJSUEIXXCENMM-UHFFFAOYSA-N phenacetin Chemical compound CCOC1=CC=C(NC(C)=O)C=C1 CPJSUEIXXCENMM-UHFFFAOYSA-N 0.000 description 2
- 239000012312 sodium hydride Substances 0.000 description 2
- 229910000104 sodium hydride Inorganic materials 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 125000006012 2-chloroethoxy group Chemical group 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 229940035676 analgesics Drugs 0.000 description 1
- 238000004166 bioassay Methods 0.000 description 1
- 235000010290 biphenyl Nutrition 0.000 description 1
- 239000004305 biphenyl Substances 0.000 description 1
- YXVFYQXJAXKLAK-UHFFFAOYSA-N biphenyl-4-ol Chemical group C1=CC(O)=CC=C1C1=CC=CC=C1 YXVFYQXJAXKLAK-UHFFFAOYSA-N 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- NLFBCYMMUAKCPC-KQQUZDAGSA-N ethyl (e)-3-[3-amino-2-cyano-1-[(e)-3-ethoxy-3-oxoprop-1-enyl]sulfanyl-3-oxoprop-1-enyl]sulfanylprop-2-enoate Chemical compound CCOC(=O)\C=C\SC(=C(C#N)C(N)=O)S\C=C\C(=O)OCC NLFBCYMMUAKCPC-KQQUZDAGSA-N 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 231100000420 gastrotoxicity Toxicity 0.000 description 1
- -1 hydrochloric acid Chemical class 0.000 description 1
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 1
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 239000012452 mother liquor Substances 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 229960003893 phenacetin Drugs 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000048 toxicity data Toxicity 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C43/00—Ethers; Compounds having groups, groups or groups
- C07C43/02—Ethers
- C07C43/20—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
- C07C43/225—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring containing halogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C39/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
- C07C39/24—Halogenated derivatives
- C07C39/367—Halogenated derivatives polycyclic non-condensed, containing only six-membered aromatic rings as cyclic parts, e.g. halogenated poly-hydroxyphenylalkanes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
- C07D239/88—Oxygen atoms
- C07D239/90—Oxygen atoms with acyclic radicals attached in position 2 or 3
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pain & Pain Management (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CS887195A CS272018B1 (en) | 1988-11-01 | 1988-11-01 | Ethereal derivatives of 4/3h/-quinazolinone |
| CSPV7195-88 | 1988-11-01 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA1316924C true CA1316924C (en) | 1993-04-27 |
Family
ID=5420647
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA000609601A Expired - Fee Related CA1316924C (en) | 1988-11-01 | 1989-08-28 | Etheric derivative of 4/3h/-quinazolinone and a process for the preparation thereof |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US4973691A (cs) |
| EP (1) | EP0367944A3 (cs) |
| JP (1) | JPH02172977A (cs) |
| AU (1) | AU4288089A (cs) |
| CA (1) | CA1316924C (cs) |
| CS (1) | CS272018B1 (cs) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5290780A (en) * | 1991-01-30 | 1994-03-01 | American Cyanamid Co. | Angiotensin II receptor blocking 2,3,6 substituted quinazolinones |
| US5204354A (en) * | 1992-02-14 | 1993-04-20 | Merck & Co., Inc. | Substituted quinazolinones as neurotensin antagonists useful in the treatment of CNS disorders |
| JP2005055674A (ja) * | 2003-08-05 | 2005-03-03 | Ricoh Co Ltd | 現像マグネットローラ、現像装置、プロセスカートリッジ及び画像形成装置 |
| TWI273911B (en) * | 2005-01-18 | 2007-02-21 | Univ Nat Chiao Tung | Prevention and amelioration of acetaminophen toxicity with tea melanin |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL131479C (cs) * | 1966-04-20 | |||
| FR2528826A1 (fr) * | 1982-06-16 | 1983-12-23 | Sanofi Sa | Nouveaux composes derives de phenols, procede de preparation desdits composes et medicaments antiseborrheiques et anti-inflammatoires contenant comme substance active au moins un desdits composes |
-
1988
- 1988-11-01 CS CS887195A patent/CS272018B1/cs unknown
-
1989
- 1989-08-28 CA CA000609601A patent/CA1316924C/en not_active Expired - Fee Related
- 1989-09-12 EP EP19890116865 patent/EP0367944A3/en not_active Ceased
- 1989-10-13 AU AU42880/89A patent/AU4288089A/en not_active Abandoned
- 1989-11-01 JP JP1283147A patent/JPH02172977A/ja active Pending
- 1989-11-01 US US07/430,293 patent/US4973691A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JPH02172977A (ja) | 1990-07-04 |
| CS272018B1 (en) | 1990-12-13 |
| EP0367944A3 (en) | 1990-12-05 |
| EP0367944A2 (en) | 1990-05-16 |
| CS719588A1 (en) | 1990-03-14 |
| US4973691A (en) | 1990-11-27 |
| AU4288089A (en) | 1990-05-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA1178594A (en) | Aminomethyl-5 oxazolidinic derivatives, the process for preparing same and the use thereof in therapeutics | |
| KR910000854B1 (ko) | 살균성 화합물의 제조방법 | |
| US4490371A (en) | N,N-Disubstituted-(2-oxo-1,2,3,5-tetrahydroimidazo-[2,1-B]quinazolinyl)oxyalkylamides | |
| US4510140A (en) | Therapeutically effective ω-(4-(2-pyridyl)-piperazino)-alkanoylanilides | |
| FR2460919A1 (fr) | Amino-ethers oxydes, leur procede de preparation et leur application en therapeutique | |
| US4188377A (en) | Carminomycin derivatives, their preparation and use | |
| US4567163A (en) | Salicyclic acid derivatives of N-acetylcysteine and pharmacological use thereof | |
| CA1316924C (en) | Etheric derivative of 4/3h/-quinazolinone and a process for the preparation thereof | |
| US3652569A (en) | Ergonine ergoptine and the 1-methyl and 9 10-dihydro derivatives thereof | |
| US4536503A (en) | Naphthoxyalkylamines and related compounds as antiinflammatory agents | |
| US4307113A (en) | Anthranilic acid derivatives | |
| KR880001320B1 (ko) | 2-시클릭아미노-2-(1, 2-벤지속사졸-3-일)아세트산 에스테르 유도체들의 제조방법 | |
| EP0085870A1 (en) | Dibenz(b,e)oxepin derivatives and pharmaceutical compositions containing them | |
| US4126625A (en) | Certain 5-substituted-3-methyl-2-benzofuran acetic acids | |
| US4136194A (en) | 2-phenyl-2-carboxyethyl 1-(p-chlorobenzoyl)-5-methoxy-2-methyl-3-indolylacetate and process for preparation thereof | |
| CA1054597A (en) | 1,6,7,8-tetrahydro-4-oxo-4h-pyrido (1,2-a) pyrimidine-9-carboalkoxy compounds | |
| KR900005018B1 (ko) | 1-아로일-5-옥소-2-피롤리딘프로판산과 그의 에스테르 및 제조방법 | |
| EP0058009A1 (en) | Novel benzanilide derivatives and pharmaceutical compositions containing them | |
| US3032556A (en) | Process for the preparation of new | |
| US2655507A (en) | Pyrazole compounds | |
| GB2106516A (en) | Anthranilic acid esters | |
| KR840000033B1 (ko) | 이소퀴놀린 유도체의 제조방법 | |
| US3109022A (en) | Nu-aryl anthranilic acids | |
| CA1154027A (en) | Derivatives of benzo¬b| furan | |
| JPS6354716B2 (cs) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MKLA | Lapsed |